FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061356 [Registered on: 11/01/2024] Trial Registered Prospectively
Last Modified On: 08/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Educational]  
Study Design  Other 
Public Title of Study   To assess the effectiveness of an intervention package on the care of children undergoing chemotherapy on the knowledge, quality of life, and caregiver burden among the parents of children diagnosed with cancer.  
Scientific Title of Study   A study to assess the effectiveness of an intervention package on the care of children undergoing chemotherapy on the knowledge, quality of life and caregiver burden among the parents of children diagnosed with cancer in selected hospital of Udupi district, Karnataka. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vaishnavi A 
Designation  Student 
Affiliation   
Address  Dept. of Child Health (Paediatric) Nursing Manipal College of Nursing MAHE, Manipal Karnataka - 576104 India

Udupi
KARNATAKA
576104
India 
Phone  8086044240  
Fax    
Email  vaishnaviashok88@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vaishnavi A 
Designation  Student 
Affiliation  Manipal College of Nursing 
Address  Manipal College of Nursing MAHE, Manipal Karnataka - 576104 India

Udupi
KARNATAKA
576104
India 
Phone  8086044240  
Fax    
Email  vaishnaviashok88@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vaishnavi A 
Designation  Student 
Affiliation   
Address  Dept. of Child Health (paediatric) Nursing Manipal College of Nursing MAHE, Manipal Karnataka - 576104 India

Udupi
KARNATAKA
576104
India 
Phone  8086044240  
Fax    
Email  vaishnaviashok88@gmail.com  
 
Source of Monetary or Material Support  
Infrastructural support: Pediatric Hematology and Oncology wards, Kasturba Hospital, Manipal 
Nil 
 
Primary Sponsor  
Name  Vaishnavi A 
Address  Manipal College of Nursing MAHE, Manipal Karnataka - 576104 India 
Type of Sponsor  Other [Self ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anjalin DSouza   Kasturba Hospital  Pediatric Hematology Oncology Wards Kasturba Hospital Madhav Nagar Manipal, Karnataka 576104
Udupi
KARNATAKA 
9845378098

anjeline.d@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Parents of children undergoing chemotherapy for cancer  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Information booklet on care of children undergoing chemotherapy and session on coping strategies for parents of children diagnosed with cancer  Information booklet on care of children undergoing chemotherapy and session on coping strategies for parents of children diagnosed with cancer for 2 days 
Comparator Agent  Not applicable  Not applicable 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Parents of children diagnosed with cancer and undergoing chemotherapy
2. Parents who are available during data collection
3. Parents who are able to read and write Kannada or English
 
 
ExclusionCriteria 
Details  1. Parents of children who are having other co-morbidities with cancer 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
knowledge  2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Quality of life and care giver burden  Day 1 - Day 16 
 
Target Sample Size   Total Sample Size="44"
Sample Size from India="44" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The study will be conducted after obtaining permission from the Department of Pediatric Hematology and Oncology of Kasturba Hospital, Manipal. The participants will be explained about the study and their participation in the research. Samples will be selected using a convenient sampling technique. The researcher has adopted a pre-experimental one-group pretest-posttest research design. Parents of children undergoing chemotherapy for cancer are the participants in the study. Data will be collected from parents while their children are admitted. The data on demographic variables will be collected by administering demographic proforma. During the pretest caregivers will be given a structured knowledge questionnaire to assess their knowledge on the care of children undergoing chemotherapy, WHO-QOL BREF 26 to assess the quality of life, and a structured burden assessment scale for parents of children diagnosed with cancer. On the same day, an information booklet on the care of children undergoing chemotherapy will be given to the parents. A session on coping strategies for parents of children diagnosed with cancer will be conducted on day 1 and day 2. The post-test will be conducted on day 16. The post-test will be conducted to assess the knowledge on the care of children undergoing chemotherapy, quality of life, and caregiver burden using the same data collection instruments. 

 
Close